Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 11:18AM ET
1.01
Dollar change
-0.02
Percentage change
-1.94
%
Index- P/E- EPS (ttm)-1.54 Insider Own0.92% Shs Outstand55.15M Perf Week0.00%
Market Cap55.70M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float54.64M Perf Month0.00%
Income-38.33M PEG- EPS next Q- Inst Own10.11% Short Float9.48% Perf Quarter-3.81%
Sales0.00M P/S- EPS this Y- Inst Trans-12.09% Short Ratio3.64 Perf Half Y-44.51%
Book/sh-0.13 P/B- EPS next Y- ROA-224.87% Short Interest5.18M Perf Year-14.41%
Cash/sh0.07 P/C13.69 EPS next 5Y- ROE-874.00% 52W Range0.50 - 1.91 Perf YTD-4.72%
Dividend Est.- P/FCF- EPS past 5Y83.15% ROI- 52W High-47.23% Beta2.36
Dividend TTM- Quick Ratio0.44 Sales past 5Y53.29% Gross Margin44.30% 52W Low102.57% ATR (14)0.12
Dividend Ex-Date- Current Ratio0.44 EPS Y/Y TTM30.59% Oper. Margin0.00% RSI (14)46.85 Volatility9.50% 11.74%
Employees17 Debt/Eq- Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price5.75
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q4.30% Payout- Rel Volume1.39 Prev Close1.03
Sales Surprise-100.00% EPS Surprise-1985.71% Sales Q/Q- EarningsNov 09 AMC Avg Volume1.42M Price1.01
SMA20-12.50% SMA5014.77% SMA200-16.04% Trades Volume619,026 Change-1.94%
Date Action Analyst Rating Change Price Target Change
Jul-21-21Initiated Cantor Fitzgerald Overweight $18
Nov-01-18Initiated Oppenheimer Outperform
Apr-02-18Initiated H.C. Wainwright Buy $11
Mar-19-18Upgrade Maxim Group Hold → Buy $13
Today 07:00AM
Mar-26-24 07:35AM
Mar-19-24 04:05PM
08:47AM
Mar-15-24 09:00AM
08:00AM Loading…
Mar-08-24 08:00AM
Mar-01-24 08:30AM
Feb-29-24 08:00AM
Feb-06-24 08:30AM
Jan-25-24 08:45AM
Jan-11-24 06:00AM
Jan-10-24 11:30AM
Jan-09-24 08:30AM
Jan-04-24 09:01AM
08:41AM
08:05PM Loading…
Jan-03-24 08:05PM
07:30AM
Dec-27-23 08:55AM
Dec-21-23 08:15AM
Dec-14-23 08:30AM
Dec-13-23 08:30AM
Dec-04-23 08:47AM
Nov-29-23 08:45AM
Nov-13-23 08:50AM
Nov-09-23 04:04PM
Nov-06-23 08:57AM
Oct-31-23 08:05AM
Oct-30-23 09:03AM
Oct-17-23 08:45AM
Oct-16-23 08:45AM
04:05PM Loading…
Oct-12-23 04:05PM
Oct-11-23 08:30AM
Oct-10-23 04:15PM
07:00AM
Sep-21-23 08:30AM
Sep-18-23 04:19PM
Aug-22-23 08:30AM
Aug-10-23 04:08PM
Jul-15-23 09:25AM
Jun-28-23 04:00PM
08:30AM
Jun-22-23 08:45AM
Jun-15-23 04:05PM
Jun-13-23 08:30AM
May-25-23 05:05PM
May-16-23 08:30AM
May-11-23 04:12PM
May-04-23 08:30AM
Apr-26-23 04:01PM
Apr-20-23 08:30AM
Apr-18-23 08:30AM
Mar-16-23 04:11PM
Mar-07-23 08:30AM
Feb-24-23 08:42AM
08:30AM
07:29AM
Feb-23-23 04:01PM
Feb-05-23 07:57AM
Jan-19-23 08:30AM
Jan-05-23 08:30AM
Dec-13-22 02:49PM
08:30AM
Dec-08-22 08:30AM
Dec-06-22 08:30AM
Dec-01-22 08:30AM
Nov-30-22 08:30AM
Nov-16-22 05:28AM
Nov-14-22 01:25PM
08:15AM
07:50AM
Nov-10-22 11:09AM
08:30AM
Nov-03-22 09:36AM
Nov-02-22 08:30AM
Oct-25-22 09:31AM
Oct-17-22 08:30AM
Oct-11-22 08:30AM
Sep-29-22 08:15AM
Sep-22-22 08:30AM
Sep-14-22 08:30AM
Sep-08-22 08:00AM
Aug-29-22 08:24AM
Aug-24-22 10:53AM
08:30AM
Aug-16-22 08:30AM
Aug-11-22 04:12PM
Aug-09-22 08:30AM
Jul-07-22 07:30AM
Jul-04-22 01:09PM
Jun-27-22 08:30AM
Jun-08-22 12:03PM
08:00AM
Jun-02-22 08:30AM
May-26-22 10:10AM
08:30AM
May-12-22 04:12PM
Apr-26-22 08:30AM
Apr-11-22 08:15AM
07:30AM
Apr-06-22 07:00AM
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.